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How to set up and apply reference levels
in fluoroscopy at a national level
Abstract A nationwide survey was
launched to investigate the use of
fluoroscopy and establish national
reference levels (RL) for dose-inten-
sive procedures. The 2-year investi-
gation covered five radiology and nine
cardiology departments in public
hospitals and private clinics, and
focused on 12 examination types: 6
diagnostic and 6 interventional. A
total of 1,000 examinations was re-
gistered. Information including the
fluoroscopy time (T), the number of
frames (N) and the dose-area product
(DAP) was provided. The data set was
used to establish the distributions of T,
N and the DAP and the associated RL
values. The examinations were pooled
to improve the statistics. A wide
variation in dose and image quality in
fixed geometry was observed. As an
example, the skin dose rate for ab-
dominal examinations varied in the
range of 10 to 45 mGy/min for
comparable image quality. A wide
variability was found for several types
of examinations, mainly complex
ones. DAP RLs of 210, 125, 80, 240,
440 and 110 Gy cm2 were established
for lower limb and iliac angiography,
cerebral angiography, coronary angi-
ography, biliary drainage and stenting,
cerebral embolization and PTCA,
respectively. The RL values estab-
lished are compared to the data
published in the literature.
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Introduction
X-ray examinations involving fluoroscopy, particularly
those performed in gastroenterology and cardiology as
well as angiography and interventional procedures, con-
tribute significantly to the total collective dose due to
medical exposure even if their frequency is relatively low.
The last survey on the exposure of the Swiss population by
X-ray imaging indicated that this contribution amounts to
up to 29% [1]. Moreover, these types of examinations
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deliver effective doses to the patient as high as 100mSv and
lead to extremely high entrance surface doses, up to a few
Gy, resulting in a significant risk of deterministic effects.
Several international bodies seriously address the issue of
radiation protection of the patient and the radiologist for
dose-intensive examinations. The International Commis-
sion on Radiological Protection (ICRP) dedicated one of its
publications to the means andmethods to use for preventing
the lesions that may be induced by interventional radiology
[2]. Similarly, the European Directive 97/43 Euratom states
in its article 9 that the “member States shall ensure that
appropriate radiological equipment, practical techniques
and ancillary equipment are used for the medical exposure
(a) of children, (b) as part of a health screening programme,
(c) involving high doses to the patient, such as interven-
tional radiology, computed tomography or radiotherapy”
[3].
In this context, in recent years reference levels (RLs)
have become of central importance in the management of
radiation doses delivered to the patient in diagnostic and
interventional radiology [4, 5]. In 2000 the National Radio-
logical Protection Board (NRPB), now part of the Health
Protection Agency, reviewed the UK national reference
levels for a number of examinations [6], in 2002 the
Swedish Radiation Protection Authority issued regulations
and general advice concerning the implementation of refer-
ence levels in Sweden [7], and in 2003 the Federal Office
for Radiological Protection (BfS) introduced reference
levels in Germany [8]. More and more effort is focused on
dose-intensive fluoroscopy examinations. At the interna-
tional level, the results of several investigations of patients’
doses have been published in the recent literature [9–28].
Since the dose-intensive examinations involving fluoros-
copy may result in a significant risk of deterministic effects,
notably to the skin, it is recommended that the entrance
surface doses be monitored for preventing skin injuries.
Some authors claim that the DAP is not a suitable quantity
for such a monitoring task because of the weak correlation
between the DAP and the entrance surface dose [29], and
that the latter should be measured directly on the patient.
But in the absence of a direct measurement, conversion
factors published in the literature [19, 30–33] may be used
to establish the maximum (peak) skin dose from the DAP.
Setting up RLs for dose-intensive examinations involving
fluoroscopy is a difficult task due to the large variability of
the fluoroscopy time and the number of images leading to a
wide distribution of patient doses. This is due to several
factors, including the often loose definition of the exami-
nation, differences in the techniques and protocols used, the
variability in the complexity of the cases and the experience
of the radiologist. In 2000 already,Marshall et al. [9] pointed
out the difficulties encountered when establishing RLs for
interventional radiology, such as the difficulty of defining a
“typical” examination, the limited number of patients and
the restriction to specialist centres. On the other hand, the
large variability related to the procedures makes it mean-
ingless in the application of RLs to compare a single
interventional examination to the RL value. These difficul-
ties may lead to the perception that even the concept of RL is
not appropriate for interventional radiology or at least to the
view that this tool should be used with caution.
To have a reliable set of RLs for a selection of exam-
inations, a large number of registrations must be made for
each type of examination, which is time and resource con-
suming. As an alternative, the pooling of all the examina-
tions registered regardless of their type is proposed to
improve the accuracy of the RL values [9].
In Switzerland the strategy for establishing RLs
consisted of: (1) launching nationwide dosimetric surveys
in order to establish national RLs for the various radiolog-
ical modalities; (2) until the results of these surveys are
available, European RL values are adopted when possible
[34, 35]; (3) in the absence of European data, provisional
RLs were calculated from average doses established by
dosimetric modelling in diagnostic and interventional
radiology during the 1998 nationwide survey on the
exposure of the public by radio-diagnostics in Switzerland
[1, 36]. The RLs were derived from the average doses using
a 1.5 multiplying factor [37].
In early 2000 the Swiss Federal Office of Public Health, in
collaboration with the University Institute of Applied Radia-
tion Physics, set up a working group on the optimisation of
radiation protection in the case of dose-intensive X-ray
examinations. The aim of the studies conducted by this
working group is to increase the awareness of the phy-
sicians, the radiographers and the medical physicists to
radiation hazards in dose-intensive examinations, in order to
improve the optimisation of the radiological technique. In
2002, the working group launched a study to investigate the
situation of fluoroscopy in Switzerland. The aim of this
study was twofold: (1) to investigate the technique used to
perform 12 common types of examinations involving
fluoroscopy in hospitals and clinics performing the bulk of
the dose-intensive examinations in Switzerland and (2) to
collect dosimetric data in order to establish RL values for the
12 types of examinations investigated. This paper describes
the method, presents the results of the investigation and
comments on the implementation of the proposed RL values
in the case of interventional radiology.
Methods
The investigation lasted 2 years and covered five radiology
and nine cardiology departments in nine public hospitals
and private clinics, and focused on 12 types of examina-
tions (6 diagnostic and 6 interventional) after a discussion
with the practitioners of the participating centres. These 12
types of examinations, which will be denoted EX01 to
EX12, are presented with a short description in Table 1.
The radiology departments belong to the five Swiss
university hospitals, whereas the nine cardiology depart-
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ments represent 36% of the cardiology practice in the Swiss
hospitals and clinics. The selection of the departments was
based on the results of the 1998 nationwide survey of the
exposure of the Swiss population to medical X-rays [1],
which covered university hospitals, regional hospitals and
clinics as well as private practices. In the case of
interventional radiology, the bulk of the examinations are
performed in university hospitals (80% on average for the
types of examinations considered in this study). For
diagnostic radiology the fraction of the total number of
examinations performed in university hospitals is lower (on
average 51% for the angiographies and 23% for the
barium-based examinations explored here).
Each centre was asked to register 20 examinations for
each of the 12 types. Four centres provided data for two
combined examinations: a procedure including coronary
angiography and percutaneous coronary intervention (PCI)
and another including electrophysiology and thermo-
ablation. These two procedures will be denoted EX13
and EX14. For each examination, the centres were
requested to fill in out a questionnaire containing various
information (fluoroscopy time, number of analogue images
and digital frames, dose-area product and difficulty of the
case) on the patient undergoing this examination (age,
gender, height and weight) and on the practitioner
performing the examination (medical specialty, number
of years of experience and number of examinations already
performed). The paper questionnaire approach proved to be
time costly, and an automatic registration would be of great
help in future surveys.
In addition to the data collected concerning the exam-
inations, the 27 fluoroscopy units used in the healthcare-
providing centres were investigated. First, the DAP meters
of the fluoroscopy units were checked using an external
reference DAP meter put on top of the measuring device
of the fluoroscopy unit. Each DAP meter was checked
twice: before the registration of the protocols and at the
end of the study. The variations between the measure-
ments were lower than 10%. Apart from two cases where
the indication of the local DAP meter was a factor of two
higher than the reference instrument, all the DAP meters
gave doses within the limits set by the Swiss Ordinance on
X-ray Units (±30%).
Unlike the American RAD-IR study [18–20] where the
fluoroscopy units were similar (Siemens, with Cu filtra-
tion), a large variability in the brands and the technical
specifications of the fluoroscopy units used in the
participating centres was registered in our case. The units
are often programmed according to the anatomical region
under investigation and operate under different modes for
Table 1 The 12 types of examinations investigated
Code Type of examination Description
Diagnostic
EX01 Barium meal Investigation of the upper GI tract (oesophagus and stomach)
EX02 Lower limb and iliac angiography Investigation of the morphology of abdominal aorta, the departure of renal arteries
and the arteries vascularising the lower limbs for the detection of aneurisms and
stenoses of the diagnose of arterioscleroses
EX03 Cerebral angiography Investigation of head and brain arteries (selective, four vessels)
EX04 Barium enema Investigation of colon using a contrast medium
EX05 Coronary angiography Examination of coronary arteries
EX06 Electrophysiology Percutanuous transluminal examination of cardiac potentials
Interventional
EX07 Hepatic embolisation Hepatic embolisation (e.g., using Lipiodol) through the hepatic arteries, aiming at
treating a haemorrhage, a tumour or an arterio-venous shunt
EX08 Biliary drainage and stent insertion Percutaneous transhepatic drain insertion in one of the biliary tracts
EX09 Cerebral embolisation Therapeutic obstruction (coiling) during the treatment of arterio-venous
malformation (MAV), of arterio-venous fistulas (FAV), intra-cranial aneurisms,
tumours or hemorrhagic lesions
EX10 Iliac dilatation and stent insertion Improvement of lower limbs perfusion
EX11 Percutaneous coronary intervention Balloon-dilatation of one or several coronary segments followed or not by stenting
EX12 Cardiac thermo ablation Local thermoablation using a catheter with a radiofrequency source of the region
of the heart responsible for arrhythmias
Diagnostic + interventional
EX13 Coronary angiography (EX05) + percutaneous
coronary intervention (EX11)
Descriptions of EX05 and EX11 above
EX14 Electrophysiology (EX06) + cardiac thermo
ablation (EX12)
Descriptions of EX06 and EX12 above
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the same irradiation geometry. The knowledge of the
parameters used for the various categories of examinations
was judged necessary. The units were therefore character-
ised in terms of the image quality, and the patient dose
associated to the various modes used. The assessment of
the image quality consisted in establishing the spatial
resolution limit at the middle of a Leeds TOR(CDR) Test
Object [38]. The dose measurements were performed using
an 11-cm3 ionisation chamber connected to a Radcal 3036
dosemeter and a 20-cm-thick PMMA phantom.
The characteristics of the fluoroscopy units (dose rate,
dose per frame, image quality index and spatial resolution)
were established for three imaging modes (radiography,
fluoroscopy and cine), various diameters (ormagnifications)
of the image intensifier and various imaging frequencies and
for six categories of examinations: (1) barium-based
examinations, (2) bile tractus examinations, (3) abdominal
and peripheral angiographies, (4) cerebral angiographies, (5)
coronary angiography and percutaneous coronary interven-
tion and (6) electro-physiology and thermo-ablation. A
summary of the results of this characterisation is given in
Table 2. The average values of the dose rates in the
fluoroscopy mode for the various categories range from
20 mGy/min for cerebral angiographies to 42 mGy/min for
coronary angiography and percutaneous coronary interven-
tion. The dose per image in the radiography mode ranges on
average from 1.6 mGy for barium-based examinations to
6 mGy for abdominal and peripheral angiographies. The
category “coronary angiography and percutaneous coronary
intervention” is a factor of 2 higher than the category
“electro-physiology and thermo-ablation” in terms of both
the dose rate (fluoroscopy) and dose per image (cine mode).
It should be mentioned that all units involved in
digestive investigations (barium-based) were relatively
old systems (15 to 10 years) working in a continuous
fluoroscopy mode, and all units dealing with cerebral
investigations (diagnostic and therapeutic) were modern
systems (5 years to less than 6 months) equipped with
copper filters and working in pulse mode. For all other
examinations, the units did not have a copper filter, but
used a pulse mode (2 to 10 years old).
The variation of the dose rate for the same irradiation
geometry was found to be of the order of a factor of 3 for
the best detection at low contrast. A significant decrease of
the dose rate was registered (a factor of 2.5–3 for a 20-cm
PPMA slab) when adding a Cu filtration.
In order to establish reference levels, the third-quartile
method is adopted in this work. It prescribes the use as a
RL of a dose value corresponding to 75% of the dose
distribution established by a dosimetric survey. This
method requires a statistically significant set of data. In
our case, the number of DAP values collected per type of
examination was relatively low, ranging from 20 to 184.
For this reason, an overall data analysis, pooling all the
examinations registered, was preferred. The hypothesis
adopted is that in relative values the distribution of the
parameters of interest such as the DAP for the pooled
examinations is not different from that obtained for one
specific examination, which will be checked statistically
using the Kolmogorov-Smirnov test. For each type of
examination, the fluoroscopy time (T), the number of
frames (N) and the DAP were divided by the geometric
mean values related to this examinations. Then the
distributions of these relative values were established in a
logarithmic scale and used to determine the RL values
using the 75th-percentile method. The use of the geometric
mean and the log scale is justified by the fact that skewed
distributions often closely fit the log-normal distribution
and are related to multiplicative effects [39]. The factors
influencing the parameters of interest such as the DAP
(e.g., patient thickness) are of a multiplicative nature.
Marshall et al. [9] have already shown that logarithmic
transformation of the DAP distributions for interventional
procedures produces reasonably normal distributions.
Table 2 Average values and standard deviations related to the dose rate, the image quality index and the spatial resolution associated with
the 27 fluoroscopy units investigated in this study and used for the various categories of examinations involving fluoroscopy
Mode Fluoroscopy Radiography Cine
Dose rate
(mGy/min)
Image
quality
index
Spatial
resolution
(mm-1)
Dose
(mGy/frame)
Image
quality
index
Spatial
resolution
(mm-1)
Dose
(mGy/frame)
Image
quality
index
Spatial
resolution
(mm-1)
Barium-based examinations 26±4 8±1 0.8±0.1 1.6±0.2 12±1 1.1±0.1 – – –
Bile tractus examinations 37±4 10±1 1.1±0.1 3.7±0.7 17±1 1.4±0.1 – – –
Abdominal and peripheral
angiographies
31±6 10±1 1.1±0.1 6.0±0.8 17±1 1.4±0.1 – – –
Cerebral angiographies 20±4 9±2 1.3±0.2 3.6±0.9 17±1 1.9±0.1 – – –
Coronary angiography and
percutaneous coronary
intervention
42±11 9±2 1.1±0.1 – – – 0.27±0.07 14±2 1.7±0.2
Electro−physiology and
thermo−ablation
24±15 10±4 1.1±0.3 – – – 0.13±0.04 13±5 2.1±0.6
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Results
During this study, 1,000 examinations were registered.
This is a good response rate since it represents 70% of the
1,440 registrations ideally expected and corresponds to an
average of 77 examinations per centre and 83 examinations
per type. The age distributions of the patients for the
various types of examinations showed a 14- to 28-year shift
to higher ages with regard to the age profile of the general
population (average ages of 53 to 67 against an average age
of 39, respectively).
The first step in order to establish RLs was to plot the
distributions of the fluoroscopy time (T), the number of
frames (N) and the DAP for all types of examinations
considered. Figure 1 gives an illustration of such distribu-
tions for one diagnostic (coronary angiography-EX05) and
EX05 ; N = 184
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Fig. 1 Distribution of the fluoroscopy time, the number of frames and the DAP for coronary angiography (EX05) and cerebral embolisation
(EX09)
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one interventional (cerebral embolisation-EX09) examina-
tion. The mean values and the ranges associated with the
distributions of T, N and the DAP for all the 14 types of
examinations addressed in this study are shown in Table 3.
The T, N and DAP distributions for the pooled patients
are shown in Fig. 2, while Fig. 3 presents the DAP
distributions specific to each of the 14 types of examina-
tions for the purpose of comparison.
From Fig. 2, the 75% values were established. They
were found to be equal to the geometric mean value
multiplied by a factor 1.70 for the fluoroscopy time, 1.47
for the number of frames and 1.72 for the DAP. The factors
established here are used to determine the 75% values in
terms of T, N and DAP for the 14 types of examinations
considered. The 75% values established from the overall
distribution (whole dataset) are compared to the 75%
values established from the distributions specific to each
type of examination (Fig. 4). The 75% values established
from the overall distribution, in terms of T, N and DAP, are
rounded and proposed as reference levels (RL) for the 14
types of examinations considered in this study. These RLs
are shown in Table 4.
Discussion
The distributions shown in Fig. 1 (linear scale) are skewed
distributions characterised by an asymmetric shape: a main
peak, a tail and a few extreme values. They are typical of
what is expected for examinations involving fluoroscopy.
Table 3 reveals interesting features about the use of
fluoroscopy in Switzerland. For barium meal (EX01) and
barium enema (EX04) examinations, fluoroscopy times
higher than 20 min are registered in some cases. Moreover,
more than 100 frames are acquired in some barium meal
procedures. This leads to DAPs as high as 400 Gy cm2. This
seems too high for this kind of diagnostic examination when
compared to the data published in the literature, notably the
UK data [6], with an average DAP of 10.3 and 23.5 vs. 67
and 114 Gy cm2 in this work for barium meal and barium
enema, respectively. However, the high values registered for
this examination may be explained by several factors.
Firstly, the definition of barium meal is quite loose and may
refer to examinations covering very different areas of the
digestive tract. Moreover, this type of examination is often
performed on old units without Cu filtration. It is often
carried out by junior radiologists with little trainingwho lack
experience on how to use the unit properly and to optimise
parameters such as the frame rate and the collimation.
Concerning lower limb angiographies (EX02), although
the average fluoroscopy time is about 7 min, some extreme
values higher than 20 min of fluoroscopy (up to 46 min) are
registered, which may be related to difficult cases. DAPs as
high as several hundredGy cm2with an average of about 180
are involved in this type of examination, for which RL values
of 33 Gy cm2 [6] and 85 Gy cm2 [8] are reported in the UK
and Germany, respectively. This examination includes iliac
angiography and can involve a wide range of vessels. It may
or may not follow a CT or an MRI procedure and thus
corresponds to awide range of selectivity of the examination.
The definition given in the questionnaire for this type of
examination may appear not specific enough. It should be
noted that this type of examination may be replaced in the
future by CT angiography [40, 41].
Similarly, cerebral angiographies (EX03) are character-
ised by an average fluoroscopy time of 13 min, but much
higher values have been found. The associated DAP can be
up to 1,000 Gy cm2 with an average of 121 Gy cm2. For
this type of examination, Brambilla et al. [17] reported a
range of DAPs from 19 to 401 Gy cm2, with an average of
158 Gy cm2. A great variability is found for this type of
procedure performed mainly at university hospitals.
Table 3 Mean values and ranges
of the fluoroscopy time, number
of frames and DAP for the
various types of examinations
Examination
code
Number of
examinations
Fluoroscopy
time (min),
mean (range)
Number of frames,
mean (range)
DAP (Gy cm2),
mean (range)
EX01 89 5.9 (0.8–35) 44 (0–201) 67 (3–441)
EX02 94 6.6 (0.2–46.7) 126 (2–372) 178 (8–747)
EX03 91 12.6 (2–85) 679 (32–5486) 121 (8–996)
EX04 41 7.8 (1.5–23.6) 17 (0–34) 114 (20–564)
EX05 184 5.7 (0.6–28.1) 1060 (10–4490) 57 (7–240)
EX06 24 3.7 (0.1–36.7) 38 (0–670) 13 (1–123)
EX07 70 22 (3.2–66) 140 (9–612) 463 (54–1703)
EX08 56 21.1 (1.3–82.5) 31 (0–119) 244 (5–1375)
EX09 58 36.5 (3.3–134) 760 (60–3348) 335 (24–1345)
EX10 72 19.2 (2–66) 158 (40–380) 344 (36–1122)
EX11 80 15.1 (2.5–49) 1,238 (259–7969) 82 (3–283)
EX12 42 22.1 (0.8–74.6) 162 (0–1270) 128 (7–495)
EX13 78 16.5 (2.6–86) 2,199 (360–6833) 178 (27–487)
EX14 21 32.4 (2.4–113) 0 (0–0) 348 (8–1442)
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Although a specific protocol was sent to the participants,
some of them have obviously provided data concerning
selective cerebral angiographies. The fluoroscopy times
may seem quite long (85 min fluoroscopy in one case), but
cerebral angiography is a complex procedure with signif-
icant implications on the quality of life of the patient who
usually is in a critical state. This examination is usually
performed by senior radiologists and hence the high doses
are due less to a lack of training than to the complexity of
the case. In the future, the use of CT and MRI for this kind
of investigation will reduce the collective dose associated
with this type of fluoroscopy examination.
Coronary angiography (EX05) and percutaneous coro-
nary intervention (EX11) and the procedure combining the
two (EX13) are characterised by a great dispersion of the
number of frames with high average values of 1,000–
2,000. The associated DAPs range from 57 to 178 Gy cm2.
This is comparable with the average values published in the
literature and compiled by Maeder et al. [42]: 6.2–109 Gy
cm2 for coronary angiography and 6.7–163 Gy cm2 for
percutaneous coronary intervention.
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Fig. 2 Distribution of the fluoroscopy time, the number of frames
and the DAP in relative values (the absolute value is divided by the
geometric mean for the given type examination) in linear (left) and
logarithmic (right) scales. Theses distributions are associated with
995 examinations (14 types)
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Regarding electrophysiological study (EX06), thermo-
ablation (EX12) and the procedure combining the two
(EX14), they are characterised by almost no frame
acquisition. Two of the three centres that provided data
for these types of examinations used fluoroscopy exclu-
sively. Thermo-ablation involves a fluoroscopy time six
times higher than electrophysiological study on average.
The DAPs involved are quite high in some cases (up to
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Fig. 3 Distributions of the DAP
in relative values (the absolute
value is divided by the geo-
metric mean for the given type
examination) in logarithmic
scale for each of the 14 types of
examinations
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about 500 Gy cm2), with average values of 13 and 128 Gy
cm2 for electrophysiology and thermo-ablation, respec-
tively. In the UK average values of 17.1 and 33.1 Gy cm2
are reported by NRPB [6] for these types of examinations,
respectively, whereas McFadden et al. reported an average
DAP of 123 Gy cm2 and a maximum value of 430 Gy cm2
for RF ablation [28].
Hepatic embolisation (EX07) and bilary drainage
(EX08) use on average the same fluoroscopy time, but
on average the former requires 4.5 times more frames than
the latter. The DAPs registered are on average 463 and
244 Gy cm2, respectively. These types of examinations are
performed on units without Cu filtration. Miller et al. [18]
reported average DAPs of 282 and 70.6 Gy cm2 for hepatic
embolisation and bilary drainage, respectively, which is
about a factor of 2 lower than our values. It is worth
mentioning that for hepatic embolisation the average T and
N in this study are 22 min and 140 frames, whereas Miller
et al. reported 16.8 min and 216 frames, respectively. The
lower value for the DAP is due to the fact that in the RAD-
IR study the fluoroscopy units were used with Cu filtration.
It appears from Table 3 that a fluoroscopy time about three
times higher is required for cerebral embolisation (EX09-
interventional) than for cerebral angiography (EX03-diag-
-
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Fig. 4 Ratio of the 75% values
of the fluoroscopy time, the
number of frames and the DAP
for the various types of exam-
inations, established in two
ways: from the distribution re-
lated to the whole set of data
(overall) and from the distribu-
tion related to the type of
examination (specific). The
number of centres involved and
the number of examinations
registered are given between
brackets on the x axis
Table 4 Reference levels (RL)
for the 14 types of examinations
considered
Examination
code
Type of examination T(min) Number of
frames
DAP
(Gy cm2)
Diagnostic
EX01 Barium meal 7 40 60
EX02 Lower limb and iliac angiography 8 150 210
EX03 Cerebral angiography 15 480 125
EX04 Barium enema 10 25 150
EX05 Coronary angiography 7 1,400 80
EX06 Electrophysiology 1 480 10
Interventional
EX07 Hepatic embolisation 30 160 620
EX08 Biliary drainage and stent insertion 25 30 240
EX09 Cerebral embolisation 50 800 440
EX10 Iliac dilatation and stent insertion 25 200 460
EX11 Percutaneous coronary intervention 20 1,500 110
EX12 Cardiac thermo-ablation 20 800 140
Combined
EX13 Coronary angiography + percutaneous coronary
intervention
20 2,800 260
EX14 Electrophysiology + cardiac thermo-ablation 30 – 280
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nostic). The average DAP related to cerebral embolisation is
335 Gy cm2, but higher values up to 1,345 Gy cm2 are
registered. Cerebral embolisations are performed in three
specialised centres on modern units with Cu filtration; they
still deliver high doses due to the complexity of the
procedure. The data published in the literature are compar-
able to the figures established in the work. Brambilla et al.
[17] reported an average DAP of 329 Gy cm2 and a
maximum of 1,221 Gy cm2 for this type of examination. On
the other hand, Miller et al. [18] reported an average value of
320 Gy cm2 and a maximum of 1,351 Gy cm2.
Similarly, the mean fluoroscopy times for iliac dilatation
and stent insertion (EX10-interventional) differ by a factor
of three from lower limb angiography (EX2-diagnostic). For
iliac dilatation and stent insertion, a large variability of the
field area is registered, depending on the localisation of the
lesion. The DAP related to iliac dilatation and stent insertion
is 344 Gy cm2 on average, with a maximum of 1,122 Gy
cm2. Miller et al. [18] reported an average DAP of 203 Gy
cm2 and a maximum of 886Gy cm2. TheDAPs registered in
the RAD-IR are therefore 70% lower on average than the
data established in this work; also the fluoroscopy times are
comparable and the number of frames is lower in our case:
on average 19.2 min and 158 frames in this investigation vs.
17.4 min and 227 frames in the RAD-IR survey. This is due
to the use of Cu filtration in the latter case.
Figure 2 shows that the distributions of the fluoroscopy
time, the number of frames and the DAP are slightly
different, but with similar shape. The full width at half
maximum related to the distribution on a logarithmic scale
gives a good indication of the data variability. The shape of
the distribution of the pooled examinations (Fig. 2) is
similar to the distributions related to specific examinations
(Fig. 3), and this holds for the T and N distributions, too.
This similarity was confirmed by the Kolmogorov-
Smirnov test (a P-value between 12.4% and 62% for ten spe-
Table 5 RL comparisons with values published in the literature
Type of examination Fluoroscopy time (min) Number of frames DAP (Gy cm2) Reference
EX01: barium meal 7 40 60 This work
– – 70 Veit and Bauer [8]
2.3 – 13 Hart et al. [6]
EX02: lower limb and iliac angiography 8 150 210 This work
– – 85 Veit and Bauer [8]
5 – 33 Hart et al. [6]
EX03: cerebral angiography 15 480 125 This work
17.5a – 198 Brambilla et al. [17]
EX04: barium enema 10 25 150 This work
– – 70 Veit and Bauer [8]
– – 50 Holm and Leitz [7]
2.7 – 31 Hart et al. [6]
EX05: coronary angiography 7 1,400 80 This work
– – 80 Holm and Leitz [7]
6 1,270 57 Neofotistou et al. [11]
EX07: hepatic embolisation 30 160 620 This work
21.5a 266a 353a Miller et al. [18]
EX08: biliary drainage 25 30 240 This work
17 – 54 Hart et al. [6]
30a 18.4a 88a Miller et al. [18]
17.3a 18a 38.3a Stratakis et al. [26]
EX09: cerebral embolisation 50 800 440 This work
12.7a – 338 Brambilla et al. [17]
112a 1,309a 400a Miller et al. [18]
EX11: percutaneous coronary intervention 20 1,500 110 This work
16 1,355 94 Neofotistou et al. [11]
23.1 1,536 69 Prieto et al. [43]
EX12: cardiac thermo-ablation 20 800 140 This work
86a – 154a,b McFadden et al. [28]
aEstablished from the mean value
bThe authors proposed three RLs of 100, 300 and 550 Gy cm2 to provide an indication of the risk of the patient suffering transient erythema,
main erythema and moist desquamation, respectively
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cific distributions, between 1.7% and 4.2% for three specific
distributions and 0.77% for one specific distribution).
The set of RLs proposed in this study are compared to data
published in the literature for ten types of examinations as
shown in Table 5. In some cases the RL was established by
multiplying the published mean value by a factor as
described above. Table 5 reveals significant differences
with the UK data, which are noticeably low. The RLs
established in this work are higher than the values proposed
in Germany for barium meal and enema and for lower limb
angiography. But our data compare well with the RLs
published by Brambilla et al. [17], Neofotistou et al. [11],
Miller et al. [18], McFadden et al. [28] and Prieto et al. [43].
Conclusion
This study allowed the collection of useful data concerning
1,000 examinations corresponding to 14 types: six diag-
nostic, six interventional and two combined. A large
variability of the dose was registered related to several
factors such as the degree of complexity of the examina-
tion, the experience of the practitioner and differences in
the definition of the examination and in the technique used.
The results of this investigation indicate that interven-
tional procedures deliver on average doses three times
higher than diagnostic examinations. The dosimetric data
base set up in this work allowed the establishment of
national RL values for the 14 types of examinations
investigated. The data collected (T, N and DAP) were
divided by the mean value for the given type of exami-
nation. The distribution of the whole set of relative values
was then used to deduce the RL using the third-quartile
method. The RLs for T range from 1 min for electrophys-
iology to 50 min for cerebral embolisation, thus covering
one order of magnitude. The RLs for N range from 25
frames for barium enema to 2,800 frames for the combined
procedure coronary angiography + percutaneous coronary
intervention, i.e., more than two orders of magnitude.
Concerning the DAP, the RLs range from 10 Gy cm2 for
electrophysiology to 620 Gy cm2 for hepatic embolisation,
i.e., a difference of a factor of 40.
The RL concept cannot be applied to a specific
examination of one patient for the types of examinations
considered here, but it is highly recommended to perform a
check, for instance, after every 20 examinations, to see if
on average the RL is exceeded systematically or not, and to
take the appropriate measures if necessary. Moreover, in
order to prevent skin injuries, the entrance surface doses
should be monitored either by direct measurements or by
converting the DAP using appropriate conversion factors
published in the literature, and patients who have under-
gone examinations with an entrance skin dose above 1 Gy,
particularly children, should be followed up.
The 75th-percentile values established in this work were
found to be higher than the RLs recommended in Germany
and the UK. This might be due to the fact that the survey
covered university hospitals mainly, where the proportion
of “heavy” cases might be relatively high and where there
is a high number of junior radiologists undergoing their
training. These high dose values should prompt a
discussion between the participating radiologists concern-
ing the specifications of the units, the choice of the
protocols and technical parameters and the training of the
staff. In particular, the use of Cu filtration should be
discussed within the community of radiologists.
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